Decision Analysis of Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome Stratified According to the Revised International Prognostic Scoring System (IPSS-R)

被引：2

作者：

Della Porta, Matteo Giovanni ^{[1
,2
]}

Alessandrino, Emilio Paolo ^{[1
,2
]}

Jackson, Christopher H. ^{[3
]}

Pascutto, Cristiana ^{[1
,2
]}

Bacigalupo, Andrea ^{[4
]}

Malcovati, Luca ^{[1
,2
]}

Van Lint, Maria Teresa ^{[5
]}

Allione, Bernardino ^{[6
]}

Bernardi, Massimo ^{[7
]}

Onida, Francesco ^{[8
,9
]}

Guidi, Stefano ^{[10
]}

Iori, Anna Paola ^{[11
]}

Cerretti, Raffaella ^{[12
]}

Marenco, Paola ^{[13
]}

Pioltelli, Pietro ^{[14
]}

Angelucci, Emanuele ^{[15
,16
]}

Bosi, Alberto ^{[10
]}

Cazzola, Mario ^{[1
,2
]}

Rambaldi, Alessandro ^{[17
]}

机构：

[1] IRCCS Fdn Policlin San Matteo, Pavia, Italy

[2] Univ Pavia, I-27100 Pavia, Italy

[3] Inst Publ Hlth, Cambridge, England

[4] IRCCS AOU San Martino IST, Genoa, Italy

[5] IRCCS AOU San Martino Hosp IST, Genoa, Italy

[6] Azienda Osped Citta Salute & Sci, Turin, Italy

[7] Ist Sci San Raffaele, I-20132 Milan, Italy

[8] Fdn IRCCS Osped Maggiore Policlin, Milan, Italy

[9] Univ Milan, Milan, Italy

[10] AO Univ Careggi, Florence, Italy

[11] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, I-00185 Rome, Italy

[12] Univ Roma Tor Vergata, Rome, Italy

[13] Osped Niguarda Ca Granda, Milan, Italy

[14] Osped San Gerardo, Monza, Italy

[15] UO Ematol, Cagliari, Italy

[16] CTMO Osped Oncol A Businco, Cagliari, Italy

[17] Azienda Osped Papa Giovanni XXIII, Bergamo, Italy

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

10.1182/blood.V124.21.531.531

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[1] Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System
M G Della Porta
C H Jackson
E P Alessandrino
M Rossi
A Bacigalupo
M T van Lint
M Bernardi
B Allione
A Bosi
S Guidi
V Santini
L Malcovati
M Ubezio
C Milanesi
E Todisco
M T Voso
P Musto
F Onida
A P Iori
R Cerretti
G Grillo
A Molteni
P Pioltelli
L Borin
E Angelucci
E Oldani
S Sica
C Pascutto
V Ferretti
A Santoro
F Bonifazi
M Cazzola
A Rambaldi
Leukemia, 2017, 31 : 2449 - 2457
[2] Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System
Della Porta, M. G.
Jackson, C. H.
Alessandrino, E. P.
Rossi, M.
Bacigalupo, A.
van Lint, M. T.
Bernardi, M.
Allione, B.
Bosi, A.
Guidi, S.
Santini, V.
Malcovati, L.
Ubezio, M.
Milanesi, C.
Todisco, E.
Voso, M. T.
Musto, P.
Onida, F.
Iori, A. P.
Cerretti, R.
Grillo, G.
Molteni, A.
Pioltelli, P.
Borin, L.
Angelucci, E.
Oldani, E.
Sica, S.
Pascutto, C.
Ferretti, V.
Santoro, A.
Bonifazi, F.
Cazzola, M.
Rambaldi, A.
LEUKEMIA, 2017, 31 (11) : 2449 - 2457
[3] The Revised International Prognostic Scoring System (IPSS-R) Predicts Posttransplantation Outcome Of Patients With Myelodysplastic Syndrome Receiving Allogeneic Stem Cell Transplantation: A Basis For Clinical Decision Making
Della Porta, Matteo G.
Alessandrino, Emilio Paolo
Bacigalupo, Andrea
Allione, Bernardino
Malcovati, Luca
van Lint, Maria Teresa
Bernardi, Massimo
Onida, Francesco
Bosi, Alberto
Iori, Anna Paola
Cerretti, Raffaella
Marenco, Paola
Pioltelli, Pietro
Angelucci, Emanuele
Oneto, Rosi
Pascutto, Cristiana
Cazzola, Mario
Rambaldi, Alessandro
BLOOD, 2013, 122 (21)
[4] Validation of the revised International Prognostic Scoring System (IPSS-R) in patients with myelodysplastic syndrome: A multicenter study
Neukirchen, Judith
Lauseker, Michael
Blum, Sabine
Giagounidis, Aristoteles
Luebbert, Michael
Martino, Samuela
Siragusa, Sergio
Schlenk, Richard F.
Platzbecker, Uwe
Hofmann, Wolf-Karsten
Goetze, Katharina
Palumbo, Giuseppe A.
Magrin, Silvana
Kuendgen, Andrea
Aul, Carlo
Hildebrandt, Barbara
Hasford, Joerg
Kobbe, Guido
Haas, Rainer
Germing, Ulrich
LEUKEMIA RESEARCH, 2014, 38 (01) : 57 - 64
[5] Comparison of International Prognostic Scoring System (IPSS) and Revised IPSS (IPSS-R) in myelodysplastic syndromes (MDS).
Mushtaq, Muhammad Umair
Ali, Abdullah
Morita, Kiyomi
Pinheiro, Ronald
Baig, Muhammad
Raza, Azra
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[6] Revised International Prognostic Scoring System (IPSS-R), stratification for myelodysplastic syndrome (MDS) patients under hypomethylating treatment
Iastrebner, M.
Flores, G.
Nucifora, E.
Kornblihtt, L.
Alfonso, G.
Rosenhain, M.
Benasayag, S.
Barcala, V.
Garcia Rivello, H.
Belli, C.
LEUKEMIA RESEARCH, 2013, 37 : S85 - S85
[7] The Revised International Prognostic Scoring System (IPSS-R) is not predictive of survival in patients with secondary myelodysplastic syndromes
Nazha, Aziz
Seastone, David P.
Keng, Michael
Hobson, Sean
Kalaycio, Matt
Maciejewski, Jaroslaw P.
Sekeres, Mikkael A.
LEUKEMIA & LYMPHOMA, 2015, 56 (12) : 3437 - 3439
[8] Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R
Della Porta, Matteo G.
Alessandrino, Emilio Paolo
Bacigalupo, Andrea
van Lint, Maria Teresa
Malcovati, Luca
Pascutto, Cristiana
Falda, Michele
Bernardi, Massimo
Onida, Francesco
Guidi, Stefano
Iori, Anna Paola
Cerretti, Raffaella
Marenco, Paola
Pioltelli, Pietro
Angelucci, Emanuele
Oneto, Rosi
Ripamonti, Francesco
Bernasconi, Paolo
Bosi, Alberto
Cazzola, Mario
Rambaldi, Alessandro
BLOOD, 2014, 123 (15) : 2333 - 2342
[9] Impact of Revised International Prognostic Scoring System (IPSS-R) on risk stratification of 555 patients with primary myelodysplastic syndrome in Taiwan
Yang, Y.
Hou, H.
Tang, J.
Chou, W.
Chen, Y.
Yao, M.
Ko, B.
Hsu, S.
Huang, S.
Chen, C.
Wu, S.
Tsay, W.
Li, C.
Lin, C.
Lee, F.
Liu, M.
Liu, C.
Tien, H.
LEUKEMIA RESEARCH, 2013, 37 : S75 - S75
[10] Revised International Prognostic Scoring System (IPSS-R) for MDS: Update
Greenberg, P.
Tuechler, H.
LEUKEMIA RESEARCH, 2013, 37 : S3 - S3

← 1 2 3 4 5 →